Alpha 1-Antitrypsin Deficiency

  • Glassia 2019 report

    Glassia 2019 U.S. PROMOTIONAL AUDIT REPORT Published July 2020 • 26 Pages The 5 Key Questions Addressed by this Report:...

  • Prolastin-C 2019 report

    Prolastin-C 2019 U.S. PROMOTIONAL AUDIT REPORT Published July 2020 • 26 Pages The 5 Key Questions Addressed by this Report:...

  • Zemaira 2019 report

    Zemaira 2019 U.S. PROMOTIONAL AUDIT REPORT Published July 2020 • 19 Pages The 5 Key Questions Addressed by this Report:...

  • Glassia 2018 report

    Glassia 2018 U.S. PROMOTIONAL AUDIT REPORT Published July 2019 • 26 Pages The 5 Key Questions Addressed by this Report:...

  • Prolastin-C 2018 report

    Prolastin-C 2018 U.S. PROMOTIONAL AUDIT REPORT Published July 2019 • 26 Pages The 5 Key Questions Addressed by this Report:...

  • Glassia 2017 report

    Glassia 2017 U.S. PROMOTIONAL AUDIT REPORT Published July 2018 • 24 Pages The 5 Key Questions Addressed by this Report:...

  • Prolastin-C 2017 report

    Prolastin-C 2017 U.S. PROMOTIONAL AUDIT REPORT Published July 2018 • 26 Pages The 5 Key Questions Addressed by this Report:...

  • Zemaira 2017 report

    Zemaira 2017 U.S. PROMOTIONAL AUDIT REPORT Published July 2018 • 24 Pages The 5 Key Questions Addressed by this Report:...

  • Glassia 2016 report

    Glassia 2016 U.S. PROMOTIONAL AUDIT REPORT Published July 2017 • 26 Pages The 5 Key Questions Addressed by this Report:...

  • Prolastin-C 2016 report

    Prolastin-C 2016 U.S. PROMOTIONAL AUDIT REPORT Published July 2017 • 26 Pages The 5 Key Questions Addressed by this Report:...

  • Zemaira 2016 report

    Zemaira 2016 U.S. PROMOTIONAL AUDIT REPORT Published July 2017 • 24 Pages The 5 Key Questions Addressed by this Report:...

  • Glassia 2015 report

    Glassia 2015 U.S. PROMOTIONAL AUDIT REPORT Published July 2016 • 29 Pages The 5 Key Questions Addressed by this...